FEATURED COMPANIES
- Amgen Inc.
- Csl Ltd.
- F. Hoffmann-La Roche Ltd.
- Glycotope Gmbh
- JSC Pharmstandard
- Novartis Ag
Report Scope:
The current report offers a detailed picture of the biologics market.
This report highlights the current and future market potential for biologics and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2025, as well as key market players.
This report details market shares for biologics based on product and geography. Based on product, the market is segmented into therapeutic proteins, vaccines and other segments.
Based on geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Detailed analyses of major countries (the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data has been provided for 2020 as the base year, with forecasts for 2020 through 2025. Estimated values are based on product manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.
Report Includes:
- 22 data tables and 26 additional tables
- An overview of the global market for biologic therapeutic drugs
- Analyses of the global market trends, with data from 2018-2020, and projections of compound annual growth rates (CAGRs) through 2025
- Evaluation of market size and market forecast; and detailed review of drivers, challenges, and opportunities affecting the global market growth
- Detailed description of product segments of biologic therapeutic drugs, such as therapeutic proteins, vaccines, cell therapy, gene therapy, blood plasma products, and others
- Assessment of the competitive environment, with a special focus on how new products and technologies are influencing the current standards of care
- Country specific data and analysis for the United States, Canada, Germany, U.K., France, Italy, Spain, Russia, China, India, Japan and other emerging economies
- Impact analysis of COVID-19 on the entire life sciences industry as well as on biologic therapeutic drugs market
- Profiles of current market leaders, as well as companies with innovative products poised to advance within the forecast period
- Company profile descriptions of major biologic therapeutic drugs manufacturers, including Amgen Inc., Baxter International, CSL Ltd., Eli Lilly and Co., F. Hoffmann-La Roche, GlaxoSmithKline Plc, Novartis and Sanofi
FEATURED COMPANIES
- Amgen Inc.
- Csl Ltd.
- F. Hoffmann-La Roche Ltd.
- Glycotope Gmbh
- JSC Pharmstandard
- Novartis Ag
Chapter 1 Introduction
- Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Analyst's Credentials
- Custom Research
- Related Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
- Biopharmaceutical Industry Structure
- Origins of Biotechnology
- Involvement of Large Pharmaceutical Companies
- Overview of Biologics
- Biologics Manufacturing
- Biopharmaceutical Manufacturing Process
- The Preparation Process
- Expression Systems for Therapeutic Protein Production
- E. coli Advantages for Microbial Production
- Mammalian Cell Therapeutic Protein Production
- FDA Regulation of Biologics
Chapter 4 Impact of COVID-19 Pandemic
- Introduction
- Short-Term Impact
- Long-Term Impact
- Delayed Approvals for Non-COVID-Related Pharmaceutical Products
- Self-Sufficiency in Pharma Industry
- Progression of COVID-19
- Government Expenditures on COVID-19
- Social Impact of COVID-19
- Impact on Insurance Providers
- Impact on Health Technology Assessment
- Changes in Consumption Trends in Health-Related Products
Chapter 5 Market Dynamics
- Market Drivers
- Overview
- Rising Prevalence of Chronic Diseases
- Advancement in Biologics
- Growing Geriatric Population
- Market Restraints
- Emergence of Biosimilars
- Market Opportunities
- Opportunities in Emerging Nations
Chapter 6 Market Breakdown by Product Segment
- Global Market for Biologic Therapeutic Drugs by Product Segment
- Therapeutic Proteins
- Vaccines
- Others
Chapter 7 Market Breakdown by Region
- Global Market for Biologic Therapeutic Drugs by Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Chapter 8 Competitive Landscape
- Porter's Five Forces Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of New Entrants
- Threat of Substitutes
- Competitive Rivalry/Degree of Competition
Chapter 9 Company Profiles
- Amgen Inc.
- Baxter
- China Biologic Products Inc.
- Csl Ltd.
- Dendreon Pharmaceuticals Llc
- Eli Lilly And Co.
- F. Hoffmann-La Roche Ltd.
- Glaxosmithkline Plc
- Glycotope Gmbh
- Grifols S.A.
- JSC Pharmstandard
- Kedrion S.P.A.
- Novartis Ag
- Octapharma Ag
- Reliance Life Sciences
- Sanofi
- Teva Pharmaceutical Industries Ltd.
List of Tables
Summary Table: Global Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
Table 1: Biologic Orphan Drugs, by Trade Name and Indication
Table 2: Expenditures on COVID-19 Crisis, by Selected Country
Table 3: Interim Economic Outlook Forecasts, by Country/Region, 2019-2021
Table 4: Number and Distribution of Persons Aged 60 and Over, by Region, 2017 and 2050
Table 5: Global Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
Table 6: Global Market for Biologic Therapeutic Proteins, by Region, Through 2025
Table 7: Global Market for Biologics Therapeutic Vaccines, by Region, Through 2025
Table 8: Global Market for Other Biologic Therapeutic Drug Products, by Region, Through 2025
Table 9: Global Market for Biologic Therapeutic Drugs, by Region, Through 2025
Table 10: North American Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
Table 11: North American Market for Biologic Therapeutic Drugs, by Country, Through 2025
Table 12: European Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
Table 13: European Market for Biologic Therapeutic Drugs, by Country, Through 2025
Table 14: Asia-Pacific Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
Table 15: Asia-Pacific Market for Biologic Therapeutic Drugs, by Country, Through 2025
Table 16: Japanese Market Statistics
Table 17: Latin American Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
Table 18: Middle Eastern and African Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
Table 19: Porter's Five Forces Analysis
Table 20: Amgen Inc.: Product Portfolio
Table 21: Baxter: Product Portfolio
Table 22: Baxter: Recent Developments, 2021
Table 23: China Biologic Products Holdings Inc.: Product Portfolio
Table 24: China Biologic Products Holdings Inc.: Pipeline Plasma Products
Table 25: China Biologic Products Holdings Inc.: Recent Developments, 2017
Table 26: CSL Ltd.: Products Portfolio
Table 27: CSL Ltd.: Recent Developments, 2021
Table 28: Dendreon Pharmaceuticals LLC: Product Portfolio
Table 29: Eli Lilly and Co.: Product Portfolio
Table 30: F. Hoffmann-La Roche Ltd.: Financials, 2019
Table 31: F. Hoffmann-La Roche Ltd.: Revenues, by Business Segment, 2016-2018
Table 32: F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 33: GlaxoSmithKline Plc: Financials, 2017-2019
Table 34: GlaxoSmithKline Plc: Products and Services
Table 35: Glycotope GmbH: Product Portfolio
Table 36: Grifols S.A.: Product Portfolio
Table 37: Grifols S.A.: Recent Developments, 2020
Table 38: JSC Pharmstandard: Product Portfolio
Table 39: Kedrion S.p.A.: Products and Services
Table 40: Kedrion S.p.A.: Developments and Strategies
Table 41: Novartis AG: Product Portfolio
Table 42: Octapharma AG: Products and Services
Table 43: Octapharma AG: Recent Developments, 2020
Table 44: Reliance Life Sciences: Product Portfolio
Table 45: Sanofi: Products and Services
Table 46: Teva Pharmaceutical Industries Ltd.: Product Portfolio
Table 47: Teva Pharmaceutical Industries Ltd.: Financials, 2017-2019
List of Figures
Summary Figure: Global Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 1: Impact of COVID-19 on the Pharmaceutical Industry
Figure 2: Comparison of GDP Growth, by Country, 2019 and 2020
Figure 3: Global Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 4: Global Market for Biologic Therapeutic Proteins, 2018-2025
Figure 5: Global Market for Biologic Therapeutic Proteins, by Region, 2018-2025
Figure 6: Global Market for Biologics Therapeutic Vaccines, 2018-2025
Figure 7: Global Market for Biologics Therapeutic Vaccines, by Region, 2018-2025
Figure 8: Global Market for Other Biologic Therapeutic Drug Products, 2018-2025
Figure 9: Global Market for Other Biologic Therapeutic Drug Products, by Region, 2018-2025
Figure 10: Global Market for Biologic Therapeutic Drugs, by Region, 2018-2025
Figure 11: Global Market Shares of Biologic Therapeutic Drugs, by Region, 2019
Figure 12: North American Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 13: North American Market Shares of Biologic Therapeutic Drugs, by Country, 2019
Figure 14: U.S. Market for Biologic Therapeutic Drugs, 2018-2025
Figure 15: Canadian Market for Biologic Therapeutic Drugs, 2018-2025
Figure 16: European Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 17: European Market Shares of Biologic Therapeutic Drugs, by Country, 2019
Figure 18: German Market for Biologic Therapeutic Drugs, 2018-2025
Figure 19: U.K. Market for Biologic Therapeutic Drugs, 2018-2025
Figure 20: French Market for Biologic Therapeutic Drugs, 2018-2025
Figure 21: Italian Market for Biologic Therapeutic Drugs, 2018-2025
Figure 22: Spanish Market for Biologic Therapeutic Drugs, 2018-2025
Figure 23: Rest of European Market for Biologic Therapeutic Drugs, 2018-2025
Figure 24: Asia-Pacific Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 25: Asia-Pacific Market Shares of Biologic Therapeutic Drugs, by Country, 2019
Figure 26: Chinese Market for Biologic Therapeutic Drugs, 2018-2025
Figure 27: Japanese Market for Biologic Therapeutic Drugs, 2018-2025
Figure 28: Indian Market for Biologic Therapeutic Drugs, 2018-2025
Figure 29: Rest of Asia-Pacific Market for Biologic Therapeutic Drugs, 2018-2025
Figure 30: Latin American Market for Biologic Therapeutic Drugs, 2018-2025
Figure 31: Latin American Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 32: Middle Eastern and African Market for Biologic Therapeutic Drugs, 2018-2025
Figure 33: Middle Eastern and African Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 34: Amgen Inc.: Annual Revenue, 2015-2019
Figure 35: Amgen Inc.: Revenue Share, by Country, 2019
Figure 36: Baxter: Annual Revenue, 2015-2019
Figure 37: Baxter: Revenue Share, by Business Unit, 2019
Figure 38: Baxter: Revenue Share, by Region, 2019
Figure 39: China Biologic Products Holdings Inc.: Financials, 2015-2019
Figure 40: China Biologic Products Holdings Inc.: Revenue Share, by Segment, 2019
Figure 41: CSL Ltd.: Financials, 2015-2019
Figure 42: CSL Ltd.: Revenue Share, by Segment, 2019
Figure 43: CSL Ltd.: Revenue Share, by Country/Region, 2019
Figure 44: Eli Lilly and Co.: Annual Revenue, 2017-2019
Figure 45: Eli Lilly and Co.: Revenue Share, by Region, 2019
Figure 46: F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Segment, 2019
Figure 47: F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, 2019
Figure 48: GlaxoSmithKline Plc: Revenue Share, by Business Segment, 2019
Figure 49: GlaxoSmithKline Plc: Revenue Share, by Region, 2019
Figure 50: Grifols S.A.: Financials, 2015-2019
Figure 51: Grifols S.A.: Revenues Share, by Segment, 2019
Figure 52: Grifols S.A.: Revenue Share, by Region, 2019
Figure 53: Kedrion S.p.A.: Financials, 2015-2019
Figure 54: Kedrion S.p.A.: Revenue Share, by Segment, 2019
Figure 55: Kedrion S.p.A.: Revenue Share, by Region, 2019
Figure 56: Novartis AG.: Annual Revenue, 2015-2019
Figure 57: Novartis AG: Revenue Share, by Region, 2019
Figure 58: Novartis AG: Revenue Share, by Business Segment, 2019
Figure 59: Octapharma AG: Financials, 2015-2019
Figure 60: Octapharma AG: Revenue, by Operating Income, 2015-2019
Figure 61: Sanofi: Annual Revenue, 2017-2019
Figure 62: Sanofi: Revenue Share, by Business Segment, 2019
Figure 63: Sanofi: Revenue Share, by Region, 2019
Figure 64: Teva Pharmaceutical Industries Ltd.: Revenue Share, by Region, 2019"
LOADING...
FEATURED COMPANIES
- Amgen Inc.
- Csl Ltd.
- F. Hoffmann-La Roche Ltd.
- Glycotope Gmbh
- JSC Pharmstandard
- Novartis Ag
The growth of the global market is attributed to the rising prevalence of chronic and acute diseases and the growing global geriatric population.
The global biologic therapeutic drug market is segmented in this report by product and region.
Reasons for Doing This Study:
The biologics market is wide-ranging and has important implications for the future of medicine and industry advancement. For companies with an effective strategy, market opportunities await. Importantly, the ability to develop an effective strategy begins where opportunity exists and ends with how to effectively execute a plan to capture profit from such opportunities.
Market growth has been spurred by the need for a more extensive pipeline from drug companies, attractive targets against challenging diseases, a push by companies to pursue biosimilars (a biologic like another biologic that has already been authorized for use) and manufacturing technologies that reduce the cost to produce profitable products.
This report seeks to address the critically important topics of changing market dynamics, emerging players and technologies, strategies for accessing emerging markets, and specific disease segments and geographies to allocate resources and make effective decisions.
- Amgen Inc.
- Baxter
- China Biologic Products Inc.
- Csl Ltd.
- Dendreon Pharmaceuticals Llc
- Eli Lilly And Co.
- F. Hoffmann-La Roche Ltd.
- Glaxosmithkline Plc
- Glycotope Gmbh
- Grifols S.A.
- JSC Pharmstandard
- Kedrion S.P.A.
- Novartis Ag
- Octapharma Ag
- Reliance Life Sciences
- Sanofi
- Teva Pharmaceutical Industries Ltd.
